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Background: Dilated cardiomyopathy (DCM) associates with mutations in the cardiac voltage-gated sodium ion channel SCN5A, but the frequency 
and causative nature of these associations remain the focus of ongoing investigation.
Methods: Whole genomic DNA samples from 338 individuals among 289 DCM families were screened for SCN5A mutations by denaturing 
high-performance liquid chromatography (DHPLC) and sequence analysis. Mutation carriers were extensively evaluated by clinical phenotype and 
pedigree.
Results: We identified 5 missense SCN5A variants among our DCM families including novel variants E446K, F1520L, and V1279I, as well as 
previously reported variants D1275N and R222Q. Out of 15 SCN5A mutation carriers in our study, 14 (93%) manifested arrhythmia: supraventricular 
arrhythmia (13/15), including sick sinus syndrome (5/15) and atrial fibrillation (9/15), ventricular tachycardia (5/15), and conduction disease 
(9/15).
Conclusions: Mutations in SCN5A were detected in 1.7% of DCM patients. Two-thirds (6 of 9) of all reported DCM mutations in SCN5A localize 
to the highly-conserved homologous S3 and S4 transmembrane segments suggesting a shared mechanism of disruption of the voltage-sensing 
mechanism of this channel leading to DCM. Not surprisingly, SCN5A mutation carriers show a strong arrhythmogenic pattern that has clinical and 
diagnostic implications.
